Maternal KIR and Fetal HLA-C Genes in Recurrent Miscarriages
NCT ID: NCT00180804
Last Updated: 2023-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2005-04-30
2005-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Association of HY-restricting HLA Class II Alleles, Sex of Firstborn Child, and Pregnancy Outcome in RPL Patients
NCT05342948
Genomic Predictors of Recurrent Pregnancy Loss
NCT05444283
Genome-wide Analysis of Single Nucleotide Polymorphisms of Brain Arteriovenous Malformations and Cerebral Aneurysm
NCT01801488
Molecular Associations With Reproductive Failure
NCT00298116
Study on the Association Between SXCI and RM and the Possible Genetic Mechanism
NCT02504281
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ashley Moffett, MRCP
Role: PRINCIPAL_INVESTIGATOR
University of Cambridge, UK
Raj Rai, MRCOG
Role: PRINCIPAL_INVESTIGATOR
Imperial College London
Preeti Jindal, MRCOG
Role: PRINCIPAL_INVESTIGATOR
St. Mary's NHS Trust, London
Winnie Lo
Role: PRINCIPAL_INVESTIGATOR
St. Mary's NHS Trust, London
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Mary's Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
05/MRE02/20
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.